Yuki Sata

Dr. Yuki Sata


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 July 2022 in Cancers
Verified
Journal Article
Open access
PDF file
YIYuki Ito
Yuki Ito
Takahiro NakajimaTakahiro Nakajima
Takahiro Nakajima
TITerunaga Inage
Terunaga Inage
TOTakeshi Otsuka
Takeshi Otsuka
YSYuki Sata
Yuki Sata
IYIchiro Yoshino
Ichiro Yoshino
Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) is a valid modality for nodal lung cancer staging. The sonographic features of EBUS helps determine suspicious lymph nodes (LNs). To facilitate this use of this method, machine-learning-based computer-aided diagnosis (CAD) of medical imaging has been introduced in clinical practice. This study investigated the feasibility of CAD for the prediction of nodal metastasis in lung cancer using endobronchial ultrasound images. Image data of patients who underwent EBUS-TBNA were collected from a video clip. Xception was used as a convolutional neural network to predict the nodal metastasis of lung cancer. The prediction accuracy of nodal metastasis through deep learning (DL) was evaluated using both the five-fold cross-validation and hold-out methods. Eighty percent of the collected images were used in five-fold cross-validation, and all the images were used for the hold-out method. Ninety-one patients (166 LNs) were enrolled in this study. A total of 5255 and 6444 extracted images from the video clip were analyzed using the five-fold cross-validation and hold-out methods, respectively. The prediction of LN metastasis by CAD using EBUS images showed high diagnostic accuracy with high specificity. CAD during EBUS-TBNA may help improve the diagnostic efficiency and reduce invasiveness of the procedure.

11 May 2026 in General Thoracic and Cardiovascular Surgery
Verified
Journal Article
Open access
PDF file
HIHiroki Imabayashi
Hiroki Imabayashi
YSYuki Sata
Yuki Sata
TITerunaga Inage
Terunaga Inage
KTKazuhisa Tanaka
Kazuhisa Tanaka
TSTakane Suzuki
Takane Suzuki
HSHidemi Suzuki
Hidemi Suzuki
We conducted a cadaveric feasibility study of two intrapleural applications of single-use bronchoscopes. In Approach 1, a 2.7 mm bronchoscope was used as a visual stylet inside a 20-Fr trocar catheter to confirm pleural entry and drain-tip position. In Approach 2, a 5.0 mm bronchoscope was used as a flexible thoracoscope for limited pleural inspection, aspiration, and direct-vision forceps biopsy; a sprayed-instillation maneuver was performed only to confirm technical deliverability. Approach 1 was attempted and feasible in six hemithoraces of three Thiel-embalmed cadavers. Approach 2 was attempted and feasible in four hemithoraces; it was not attempted in two hemithoraces due to time constraints and a large persistent air leak after Approach (1) No negative-to-positive conversion (new persistent air leak) was observed after Approach (2) These techniques may offer complementary approaches to conventional methods for observing the intrathoracic space and therefore warrant stepwise clinical validation.

26 September 2025 in Cancers
Verified
Journal Article
Open access
PDF file
YSYuki Sata
Yuki Sata
TITerunaga Inage
Terunaga Inage
Takahiro NakajimaTakahiro Nakajima
Takahiro Nakajima
YIYuki Ito
Yuki Ito
IYIchiro Yoshino
Ichiro Yoshino
HSHidemi Suzuki
Hidemi Suzuki
Background/Objectives: Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) is a well-established, minimally invasive method for sampling mediastinal and hilar lymph nodes. It has high sensitivity and specificity for diagnosing lymph node involvement. However, achieving a definitive cytopathological diagnosis can be challenging owing to the limited presence of atypical tumor cells. The scanning single-molecule counting (SSMC) method enables rapid measurement of target molecule expression. This study assessed the correlation between miR-200c expression measured by SSMC and lymph node metastasis confirmed by cytopathology. Methods: Following EBUS-TBNA in patients with lung cancer or suspected lung cancer, we flushed 22-gauge biopsy needles with 1 mL saline and extracted microRNA (miRNA) from the lavage fluid. The quality of SSMC results for miR-200c was evaluated and compared with that of quantitative real-time polymerase chain reaction (RT-qPCR). Results: Linear regression analysis of miR-200c between SSMC and RT-qPCR showed a statistically significant positive correlation (R2 = 0.81, p < 0.0001), demonstrating the feasibility of SSMC for evaluating miRNA in lymph nodes. Based on these findings, we enrolled and analyzed 100 lymph nodes from 86 patients. High miR-200c expression detected lymph node metastasis with high sensitivity (85.7%) and specificity (83.3%) and an AUC of 0.88. No discordance was observed between the standard SSMC and rapid methods. Conclusions: The expression of miR-200c, as measured by SSMC, may serve as a biomarker for molecular nodal staging. The rapid SSMC method provides results within 30 min, significantly faster than conventional RT-qPCR, and may complement rapid on-site cytological evaluation.

1 January 2026 in Surgical Case Reports
Verified
Journal Article
Open access
PDF file
HIHiroki Imabayashi
Hiroki Imabayashi
YSYuki Sata
Yuki Sata
TTTakahide Toyoda
Takahide Toyoda
TITerunaga Inage
Terunaga Inage
KTKazuhisa Tanaka
Kazuhisa Tanaka
HSHidemi Suzuki
Hidemi Suzuki
INTRODUCTION: Castleman disease is a rare benign lymphoproliferative disorder characterized by lymph node hyperplasia. Unicentric Castleman disease (UCD) involves a single anatomical region. Complete surgical resection remains the standard treatment. Lesions in the middle mediastinum can become large and technically demanding because of their proximity to the trachea, esophagus, and major vessels. Although video-assisted thoracoscopic surgery has been used in selected cases, reports of robot-assisted thoracic surgery (RATS) for giant UCD arising in the subcarinal middle mediastinum remain extremely limited. Herein, we report a case illustrating the feasibility and potential advantages of RATS in the treatment of giant middle mediastinal UCD.CASE PRESENTATION: A man in his 40s was incidentally found to have a 9.2 × 6.4 cm middle mediastinal mass beneath the tracheal bifurcation on chest imaging. The patient was asymptomatic, and laboratory tests, including interleukin-6 and tumor markers, yielded normal results. Fluorodeoxyglucose PET/CT demonstrated a homogeneous lesion with mild uptake. Endobronchial US-guided transbronchial needle aspiration was nondiagnostic, and upper gastrointestinal endoscopy showed no direct invasion of the esophagus. Although UCD was suspected, the differential diagnoses included malignant lymphoma and a solitary fibrous tumor. Complete surgical resection was planned for both diagnosis and treatment because of the uncertain diagnosis, the tumor size, and its location. The tumor was mobilized and removed en bloc using right-sided RATS with 4 robotic ports and 1 assistant port. The robotic platform provided 3D visualization, articulated instrumentation, and precise dissection, particularly around the right main bronchus, esophagus, azygos vein, and posterior aspect of the tumor. The operative time was 311 min, and the estimated blood loss was 200 mL, with no major intraoperative bleeding or postoperative complications. Histopathology confirmed hyaline-vascular-type UCD, and margin-negative resection was achieved. The postoperative recovery was uneventful, and the patient was discharged on POD 5.CONCLUSIONS: When combined with meticulous preoperative planning and strategic port placement, RATS may offer a feasible minimally invasive approach for managing large mediastinal tumors in challenging locations.